No Data
No Data
10-K: FY2024 Annual Report
Carmell Names Patrick Sturgeon as Vice Chairman >CTCX
Carmell Sees FY25 Revenue $3 to $4 M From Current Pipeline Before Any New Pdt Launches or Additional Partnerships, Acquisitions >CTCX
Carmell Therapeutics Files $100M Mixed Securities Shelf
Express News | Carmell: Resale Prospectus Covers Offering of up to 17.4 Mln Common Shares That May Be Sold in One or More Offerings by Selling Stockholders
Express News | Carmell Corp Files for Mixed Shelf of up to $100 Mln - SEC Filing